切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2022, Vol. 16 ›› Issue (11) : 1050 -1053. doi: 10.3877/cma.j.issn.1674-0785.2022.11.004

所属专题: 乳腺疾病 指南共识

专家论坛

《中国妊娠期与哺乳期乳腺癌临床实践指南(2022版)》基本问题解读
陈青1, 吴克瑾1,()   
  1. 1. 200011 上海,复旦大学附属妇产科医院乳腺科
  • 收稿日期:2022-05-31 出版日期:2022-11-15
  • 通信作者: 吴克瑾

Interpretation of basic contents of Clinical Practice China Guidelines for Breast Cancer during Pregnancy and Lactation (2022 edition)

Qing Chen1, Kejin Wu1,()   

  1. 1. Department of Breast Surgery, Obstetrics & Gynecology Hospital of Fudan University, Shanghai 200011, China
  • Received:2022-05-31 Published:2022-11-15
  • Corresponding author: Kejin Wu
引用本文:

陈青, 吴克瑾. 《中国妊娠期与哺乳期乳腺癌临床实践指南(2022版)》基本问题解读[J/OL]. 中华临床医师杂志(电子版), 2022, 16(11): 1050-1053.

Qing Chen, Kejin Wu. Interpretation of basic contents of Clinical Practice China Guidelines for Breast Cancer during Pregnancy and Lactation (2022 edition)[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(11): 1050-1053.

妊娠期与哺乳期乳腺癌由于生理上的改变以及诊疗措施可能对子代产生影响,其临床诊治具有独特性与复杂性。然而,国内相关研究较少且缺乏规范的临床诊治流程。中华医学会外科学分会乳腺外科学组组织编写的《中国妊娠期与哺乳期乳腺癌临床实践指南(2022版)》参考GRADE系统标准将临床研究证据分类,优先选择Ⅰ类和Ⅱ类证据纳入评价体系,并结合中国临床研究特点和临床实践的可及性作出不同强度的推荐意见。本文对该指南中的基本问题进行解读,以期为国内乳腺外科医师临床工作提供参考。

Because of the physiological changes and the possible affection of diagnostic and treatment measures, the clinical management of breast cancer during pregnancy and lactation is unique and complex. However, there is only little related research and no standardized clinical diagnosis and treatment procedures exist in China. Therefore, the Chinese Society of Breast Surgery evaluated the level of evidence in clinical research of breast cancer during pregnancy and lactation by referring to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. Based on the currently available high-quality level Ⅰ or Ⅱ evidence, the clinical characteristics of patients, and the accessibility of the clinical practice of breast surgery, the Clinical Practice Guideline for Breast Cancer during Pregnancy and Lactation 2022 was formulated. This article interprets the basic contents of the guidelines to provide reference for the clinical work of breast surgeons in China.

1
王富文, 傅少梅, 金玉春, 等. 妊娠期乳腺癌临床诊治回顾性分析 [J].中华外科杂志, 2018, 56(2):114-118.
2
吴克瑾. 从多学科协作入手加强妊娠期乳腺癌个案管理 [J].中华外科杂志, 2020, 58(2):95-98.
3
中华医学会外科学分会乳腺外科学组. 妊娠相关性乳腺癌临床诊治专家共识(2022版) [J]. 中华临床医师杂志(电子版), 2022, 14(5): 321-325.
4
Chen Q, Qiu YR, Zhang MD, et al. Clinical practice guidelines for pregnancy-associated breast cancer: Chinese society of breast surgery (CSBrS) practice guidelines 2021 [J]. Chin Med J (Engl), 2021, 134(20):2395-2397.
5
中华医学会外科学分会乳腺外科学组. 中国妊娠期与哺乳期乳腺癌临床实践指南(2022版) [J].中国实用外科杂志, 2022, 42(2):146-150.
6
Amant F, Lefrère H, Borges VF, et al. The definition of pregnancy-associated breast cancer is outdated and should no longer be used [J]. Lancet Oncol, 2021, 22(6):753-754.
7
Jerzak KJ, Lipton N, Nofech-Mozes S, et al. Clinical outcomes and prognostic biomarkers among pregnant, post-partum and nulliparous women with breast cancer: a prospective cohort study [J]. Breast Cancer Res Treat, 2021, 189(3):797-806.
8
Sun J, Lee MC. Clinical presentation, diagnosis and prognosis of pregnancy-associated breast cancer [J]. Adv Exp Med Biol, 2020, 1252:87-93.
9
Viswanathan S, Ramaswamy B. Pregnancy-associated breast cancer [J]. Clin Obstet Gynecol, 2011, 54(4):546-555.
10
Committee Opinion No. 723: Guidelines for diagnostic imaging during pregnancy and lactation [J]. Obstet Gynecol, 2017, 130(4):e210-e216.
11
Robbins J, Jeffries D, Roubidoux M, et al. Accuracy of diagnostic mammography and breast ultrasound during pregnancy and lactation [J]. AJR Am J Roentgenol, 2011, 196(3):716-722.
12
Torloni MR, Vedmedovska N, Merialdi M, et al. Safety of ultrasonography in pregnancy: WHO systematic review of the literature and meta-analysis [J]. Ultrasound Obstet Gynecol, 2009, 33(5):599-608.
13
Amant F, Loibl S, Neven P, et al. Breast cancer in pregnancy [J]. Lancet, 2012, 379(9815):570-579.
14
Loibl S, Schmidt A, Gentilini O, et al. Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients [J]. JAMA Oncol, 2015, 1(8):1145-1153.
15
Shannon J, Douglas-Jones AG, Dallimore NS. Conversion to core biopsy in preoperative diagnosis of breast lesions: is it justified by results? [J]. J Clin Pathol, 2001, 54(10):762-765.
16
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (2022-Breast Version 2) [EB/OL]. [2021-12-20].

URL    
17
Peccatori FA, Azim HAJr, Orecchia R, et al. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J]. Ann Oncol, 2013, 24 Suppl 6:vi160-170.
18
Shachar SS, Gallagher K, McGuire K, et al. Multidisciplinary management of breast cancer during pregnancy [J]. Oncologist, 2017, 22(3):324-334.
19
Ray JG, Vermeulen MJ, Bharatha A, et al. Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes [J]. JAMA, 2016, 316(9):952-961.
20
马田雨, 代文杰. 妊娠期乳腺癌诊断及治疗进展 [J].中国实用外科杂志, 2014,(4):376-378.
21
Ring AE, Smith IE, Jones A, et al. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals [J]. J Clin Oncol, 2005, 23(18):4192-4197.
22
Amant F, Vandenbroucke T, Verheecke M, et al. Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy [J]. N Engl J Med, 2015, 373(19):1824-1834.
23
>ACOG Committee Opinion No. 775: Nonobstetric Surgery During Pregnancy [J]. Obstet Gynecol, 2019, 133(4):e285-e286.
24
Arkenbosch J, van Ruler O, de Vries AC. Non-obstetric surgery in pregnancy (including bowel surgery and gallbladder surgery) [J]. Best Pract Res Clin Gastroenterol, 2020, 44-45:101669.
25
Tolcher MC, Fisher WE, Clark SL. Nonobstetric Surgery During Pregnancy [J]. Obstet Gynecol, 2018, 132(2):395-403.
26
Guyatt GH, Akl EA, Crowther M, et al. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J]. Chest, 2012, 141(2 Suppl):7S-47S.
27
Upadya M, Saneesh PJ. Anaesthesia for non-obstetric surgery during pregnancy [J]. Indian J Anaesth, 2016, 60(4):234-241.
28
American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 171: Management of Preterm Labor [J]. Obstet Gynecol, 2016, 128(4):e155-164.
29
Loibl S, Han SN, von Minckwitz G, et al. Treatment of breast cancer during pregnancy: an observational study [J]. Lancet Oncol, 2012, 13(9):887-896.
30
Annane K, Bellocq JP, Brettes JP, et al. Infiltrative breast cancer during pregnancy and conservative surgery [J]. Fetal Diagn Ther, 2005, 20(5):442-444.
31
Gentilini O, Cremonesi M, Trifirò G, et al. Safety of sentinel node biopsy in pregnant patients with breast cancer [J]. Ann Oncol, 2004, 15(9):1348-1351.
32
Pandit-Taskar N, Dauer LT, Montgomery L, et al. Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients [J]. J Nucl Med, 2006, 47(7):1202-1208.
33
Gentilini O, Cremonesi M, Toesca A, et al. Sentinel lymph node biopsy in pregnant patients with breast cancer [J]. Eur J Nucl Med Mol Imaging, 2010, 37(1):78-83.
34
Bae SY, Kim KS, Kim JS, et al. Neoadjuvant chemotherapy and prognosis of pregnancy-associated breast cancer: a time-trends study of the Korean Breast Cancer Registry Database [J]. J Breast Cancer, 2018, 21(4):425-432.
35
Peccatori FA, Lambertini M, Scarfone G, et al. Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences [J]. Cancer Biol Med, 2018, 15(1):6-13.
36
Germann N, Goffinet F, Goldwasser F. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients [J]. Ann Oncol, 2004, 15(1):146-150.
37
Amant F, Van Calsteren K, Halaska MJ, et al. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study [J]. Lancet Oncol, 2012, 13(3):256-264.
38
de Haan J, Verheecke M, Van Calsteren K, et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients [J]. Lancet Oncol, 2018, 19(3):337-346.
39
National Toxicology Program. NTP Monograph: Developmental effects and pregnancy outcomes associated with cancer chemotherapy use during pregnancy [J]. NTP Monogr, 2013,(2):i-214.
40
Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy [J]. Lancet Oncol, 2004, 5(5):283-291.
41
Pistilli B, Bellettini G, Giovannetti E, et al. Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: how should we counsel cancer patients about breastfeeding? [J]. Cancer Treat Rev, 2013, 39(3):207-211.
42
Griffin SJ, Milla M, Baker TE, et al. Transfer of carboplatin and paclitaxel into breast milk [J]. J Hum Lact, 2012, 28(4):457-459.
43
吴克瑾, 陈玉芸, 金玉春, 等. 年轻女性早期乳腺癌病人生育相关调查研究 [J].中国实用外科杂志, 2021, 41(11):1262-1268.
44
ESHRE Guideline Group on Female Fertility Preservation, Anderson RA, Amant F, et al. ESHRE guideline: female fertility preservation [J]. Hum Reprod Open, 2020, 2020(4):hoaa052.
45
Gundelach T, Stuck D, Widschwendter P, et al. Fertility preservation after caesarean delivery in a woman diagnosed with Morbus Hodgkin disease during pregnancy [J]. J Assist Reprod Genet, 2014, 31(1):51-53.
46
Pereira N, Kligman I, Hunt R, et al. Fertility preservation with random-start controlled ovarian stimulation and embryo cryopreservation for early pregnancy-associated breast cancer [J]. Gynecol Endocrinol, 2019, 35(3):214-216.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[3] 刘伟, 牛云峰, 安杰. LINC01232 通过miR-516a-5p/BCL9 轴促进三阴性乳腺癌的恶性进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 330-338.
[4] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[5] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[6] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[7] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[8] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[9] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[10] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[11] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[12] 刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
[13] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[14] 王帅, 张志远, 苏雨晴, 李雯雯, 王守凯, 刘琦, 李文涛. 孟德尔随机化及其在乳腺癌研究中的应用进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 671-676.
[15] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?